Gabapentin Toxicity Management
For acute gabapentin overdose, provide supportive care with airway management, respiratory support, and hemodynamic monitoring as the primary treatment, with hemodialysis reserved for severe toxicity, particularly in patients with renal impairment or life-threatening symptoms.
Immediate Management Approach
The cornerstone of gabapentin toxicity management is supportive care 1. There is no specific antidote for gabapentin overdose. Your immediate priorities should follow this algorithm:
1. Airway and Respiratory Support
- Establish airway patency and provide bag-mask ventilation if needed
- Proceed to endotracheal intubation for patients with:
- Loss of protective airway reflexes
- Severe CNS depression with respiratory compromise
- Inability to maintain adequate oxygenation
2. Monitor for Specific Toxicity Manifestations
Acute gabapentin overdoses (up to 49 grams reported) typically present with 1:
- CNS effects: Double vision, slurred speech, drowsiness, lethargy, sedation
- Gastrointestinal: Diarrhea
- Neuromuscular: Ataxia, myoclonus (especially with renal impairment) 2
- Severe complications:
3. Critical Laboratory Monitoring
Obtain immediately and monitor serially:
- Creatine phosphokinase (CPK): Check for rhabdomyolysis, particularly if CPK >3× upper limit of normal 3
- Renal function: Creatinine, BUN, creatinine clearance
- Electrolytes: Monitor for complications from rhabdomyolysis
- Urinalysis: Assess for myoglobinuria if rhabdomyolysis suspected
Hemodialysis Indications
Hemodialysis is the definitive extracorporeal treatment for severe gabapentin toxicity 1. Consider hemodialysis for:
- Patients with significant renal impairment (gabapentin is 100% renally cleared)
- Life-threatening symptoms including coma
- Severe rhabdomyolysis with acute kidney injury 4
- Persistent severe CNS depression despite supportive care
Hemodialysis effectively removes gabapentin, though the FDA label notes it has not been performed in many reported overdose cases 1. For patients on peritoneal dialysis, continuous automated cycling PD provides significant clearance with an elimination half-life of 41.33 hours (versus 132 hours without dialysis), though this is slower than hemodialysis 5.
Critical Pitfalls and Special Considerations
Polypharmacy and Drug Interactions
- 89.5% of gabapentin toxicity cases involve multiple comorbidities and polypharmacy 3
- Co-ingestion with opioids or CNS depressants significantly increases morbidity and mortality risk
- Statin co-administration increases rhabdomyolysis risk—7 cases documented symptom onset after combination therapy 3
- Always administer naloxone if opioid co-ingestion is suspected, regardless of gabapentin involvement
Renal Function Considerations
Gabapentin accumulates rapidly in renal impairment since it is exclusively cleared by the kidneys 1. Patients with:
- Chronic kidney disease: Higher risk of severe toxicity even at therapeutic doses
- Acute kidney injury: May develop from rhabdomyolysis, creating a vicious cycle requiring dialysis 4
Myoclonus as a Red Flag
Myoclonic activity is a specific complication of gabapentin toxicity, especially with renal disease 2. This resolves with:
- Discontinuation of gabapentin
- Hemodialysis or peritoneal dialysis treatment
Disposition and Recovery Timeline
- Most patients recover fully with supportive care alone 1
- Biochemical resolution occurs in 78.9% of cases with median recovery time of 14 days 3
- Symptom improvement typically begins within 36 hours of intensive dialysis 5
- One mortality has been reported, resulting from comorbid complications rather than gabapentin toxicity alone 3
Contact Poison Control
For complex cases or uncertainty in management, contact your regional poison center at 1-800-222-1222 (United States) for expert toxicology consultation 6.